<DOC>
	<DOCNO>NCT02615561</DOCNO>
	<brief_summary>1 . Curing mild atopic dermatis child commerical medical device ( Bepanthen Itch Relief Cream ) . 2 . Maintaining healthy skin use new cosmetic Bepanthen product commercially available cosmetic product</brief_summary>
	<brief_title>Curing Atopic Dermatits Children With Commerical Medical Device Maintaining Healthy Skin Using New Cosmetic Product</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Pantothenic Acid</mesh_term>
	<criteria>Written parent ' informed consent child participate study attend study procedure process outline protocol Male female babies/children age 1 month 4 year Mild AD present maximum SCORAD 25 ( Screening Baseline ) Acute flareup phase Local SCORAD â‰¥ 5 target area ( Screening Baseline ) Skin type I IV accord Fitzpatrick Any skin disease target area would interfere clinical assessment opinion investigator Known allergies ingredient IMPs Any adjuvant therapy AD ( UV therapy , probiotic , homeopathy etc . ) within 30 day Baseline well entire study Any use another topical emollient establish treatment AD Phase 1 ( cure phase ) Phase 2 ( care phase ) site flare ( AD lesion ) . Exception usual hygienic product nappy area</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Atopic dermatitis</keyword>
	<keyword>Cosmetic product</keyword>
</DOC>